On July 21, 2026, Strata Critical Medical (Nasdaq: SRTA) announced that they will reveal their financial results for the second quarter ending July 31, 2026, on August 4, 2026, before the market's opening. A conference call is scheduled for the same day at 8:00 am Eastern Time with Melissa Tomkiel, Co-CEO and General Counsel, and Will Heyburn, Co-CEO and CFO. The call will provide an opportunity for participants to engage in a question-and-answer session.